Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 15, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 14, 2009

Conditions
Breast Cancer
Interventions
DRUG

Liposomal Doxorubicin

DRUG

Cyclophosphamide

DRUG

Trastuzumab

Trial Locations (12)

11009

Hospital Puerta del Mar, Cadiz

12002

Hospital Provincial de Castellón, Castelló

15006

Hospital Juan Canalejo, A Coruña

15009

Centro Oncológico Regional de Galicia, A Coruña

23007

Complejo Hospitalario de Jaen, Jaén

27004

Hospital Xeral Calde de Lugo, Lugo

28021

Hospital Universitario Doce de Octubre, Madrid

28040

Hospital Clínico Universitario San Carlos, Madrid

28922

Fundación Hospital Alcorcón, Alcorcón

38010

Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife

08916

Hospital Germans Trias i Pujol, Badalona

08036

Hospital Clinic i Provincial, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

Spanish Breast Cancer Research Group

OTHER